Meet the doctor — Ashraf Abaza, MD
  • Chief, Consultation-Liaison Psychiatry, and ECT services, U.S. Department of Veteran Affairs, Northport VA Medical Center, New York
  • Assistant Professor of Clinical Psychiatry, Stony Brook Medical School, New York State University at Stony Brook, New York from 1994 to 2012
  • Board Certified, American Board of Psychiatry and Neurology (ABPN) 1995. Eligible for American Board of Psychosomatic Medicine.
  • Dr. Abaza graduated with honors from the renowned School of Medicine at the University of Alexandria, Egypt, in 1984. He ran a private practice from 1985-1990. He completed his residency training in Psychiatry and served as a chief resident at the Brookdale hospital Medical center and SUNY @ Downstate, New York in 1994.
  • Completed a fellowship in Consultation-liaison Psychiatry from SUNY@ Stony Brook in 1995 where he gained experience in treating psychiatric disorders in the context of severe medical illness and burn traumas.
  • Areas of special interest and experience include : Resistant depression, Postpartum Depression, Medical and psychiatric conditions associated with depression, Complex psychopharmacology and Electroconvulsive therapy (ECT), as well as Post Traumatic Stress Disorder (PTSD)
  • Dr. Abaza also has an interest in Disaster Psychiatry and worked with families of victims of airline crashes, including Egypt-Air crash in 1999 off the shores of long Island and Nantucket.
  • Dr. Abaza lead task forces on suicide prevention at the Northport VA medical center and has an extensive experience in suicide prevention among veterans, University students and geriatric populations.
Personal Statement from Dr. Abaza
I have spent the past 25 years successfully treating clinical depression and gained substantial experience in the various presentations of resistant depression and associated psychiatric and medical complications. I have utilized a variety of treatment options including complex psychopharmacology, Electroconvulsive therapy (ECT), and individual psychotherapy, as well as combinations of all three. Although most patients improved to a meaningful extent, I have always been unhappy about the side effects of medications that they suffered from year after year. I have seen near miraculous improvement in severe cases of depression with ECT therapy, however, I understood patients fear of general anesthesia and always wished for a treatment that could achieve comparable results without all downsides of Electroconvulsive therapy. Now that TMS is FDA approved and clinical results seem to exceed the results of the clinical studies that lead to the FDA approval of the treatment system, I am very happy to have lived to see that day come true. I am proud to be the first practice on Suffolk county to provide this innovative, safe, and cost-effective treatment to the residents of Suffolk county and all of Long Island, New York. Ashraf Abaza, MD New York. October, 2009